Komori
General Meetings of Shareholders4891TMS Co.,Ltd.Pharmaceuticals

Notice Concerning Responses to Questions Received and the Q&A Session at the 22nd Annual General Meeting of Shareholders

The company disclosed responses to recently received questions and the Q&A from the 22nd Annual General Meeting of Shareholders. The meeting was already held on 27 March 2026. This is not a disclosure of the voting results on proposals or guidance on the procedures for convening the meeting.

Worth reading
17Immaterial
Scored from 1 of 4 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Conditional
How definitive the wording is.

Resolutions for the General Meeting of Shareholders

Annual (22nd)
2026
Mar 27
Date and time
Resolutions for the General Meeting of Shareholders
ItemDetails
Type of shareholders' meetingAnnual (22nd)
Date and time27 March 2026
Items this document does not state (4)
Matters for resolutionShareholder ProposalDirector nomineePercentage voting in favor

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To provide fair disclosure of information to stakeholders from the perspective of fair disclosure. In consideration of investor convenience, the questions and answers were summarized, edited and published.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Concerning Responses to Questions Received and the Q&A Session at the 22nd Annual General Meeting of Shareholders | TMS Co.,Ltd. (4891) timely disclosure | Komori